Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PLK1 | P53350 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 5/20 | 0.38 |
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16757623 | 1.00 | MEN1 (0.43) | MEN1KMT2AGAAPLK1TDP1 | |
| SCHEMBL31756841 | 0.90 | PLK1 (0.42) | MEN1KMT2APLK1CA2TLR2 | |
| SCHEMBL26232048 | 0.90 | PLK1 (0.42) | MEN1KMT2APLK1CA2TLR2 | |
| SCHEMBL16791114 | 0.90 | PLK1 (0.42) | MEN1KMT2APLK1CA2TLR2 | |
| SCHEMBL29131983 | 0.90 | PLK1 (0.42) | MEN1KMT2APLK1CA2TLR2 | |
| SCHEMBL23417972 | 0.90 | TLR2 (0.44) | MEN1KMT2APLK1CA2TLR2 | |
| SCHEMBL16757612 | 0.89 | TLR2 (0.45) | MEN1KMT2AGAAPLK1CA2 | |
| SCHEMBL21836141 | 0.89 | TLR2 (0.45) | MEN1KMT2AGAAPLK1CA2 | |
| SCHEMBL25132967 | 0.86 | PLK1 (0.42) | MEN1KMT2AGAAPLK1TDP1 | |
| SCHEMBL19732528 | 0.85 | TDP1 (0.48) | MEN1KMT2AGAATDP1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4592275-A2 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | Redwood Bioscience, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-3074010-B1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE INC (US) | 2025-05-14 | — | — | EP | disclosed |
| US-12215080-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2025-02-04 | — | — | US | disclosed |
| US-20220153696-A1 | Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2022-05-19 | — | — | US | disclosed |
| US-11180451-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2021-11-23 | — | — | US | disclosed |
| US-20200317610-A1 | Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2020-10-08 | — | — | US | disclosed |
| US-10604483-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2020-03-31 | — | — | US | disclosed |
| US-10464894-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCES, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| US-20170049907-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | CATALENT PHARMA SOLUTIONS, LLC | 2017-02-23 | — | — | US | disclosed |
| US-9493413-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| EP-3074010-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | Redwood Bioscience, Inc. (US) | 2016-10-05 | — | — | EP | disclosed |
| US-20150157736-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | R.P. SCHERER TECHNOLOGIES, LLC | 2015-06-11 | — | — | US | disclosed |
| WO-2015081282-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE, INC. (US) | 2015-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150157736-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-20220153696-A1 | Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-20170049907-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-12215080-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-11180451-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-10464894-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-10604483-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
| US-20200317610-A1 | Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate | DNPEP, QPCT, PDS5A | MEN1 903/4885KMT2A 1630/4885GAA 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.